How does TB-500 work?

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide that regulates actin polymerization. It promotes cell migration, angiogenesis (new blood vessel formation), and tissue repair by upregulating actin and the cell-surface receptor PINCH. It has systemic effects, unlike BPC-157 which is more localized.

How does TB-500 compare to BPC-157?

TB-500 and BPC-157 are complementary injury recovery peptides. TB-500 works systemically via actin regulation and promotes cell migration throughout the body. BPC-157 works more locally, promoting angiogenesis and collagen synthesis at the injury site. The 'healing stack' combines both for synergistic repair — TB-500 for systemic recovery, BPC-157 for local healing.

What conditions is TB-500 used for in research?

TB-500 research has focused on tendon and ligament injuries, muscle tears, cardiac repair (post-infarction), wound healing, and neurological recovery. It has shown particular promise for chronic tendinopathies and injuries that are slow to heal with conventional treatment.

What are the side effects of TB-500?

TB-500 has a favorable safety profile in preclinical research. Common effects include mild fatigue and head rush immediately after injection. Injection site reactions (redness, swelling) are occasionally reported. No serious adverse events have been reported at standard research doses. Long-term human safety data is limited.

Can TB-500 be injected locally or systemically?

TB-500 can be injected subcutaneously (systemic) or locally near the injury site. Systemic injection is more common and produces body-wide effects. Local injection near the injury site may concentrate effects at the target area. Both routes are used in research — systemic injection is simpler and still effective.

Is TB-500 the same as Thymosin Beta-4?

TB-500 is a synthetic fragment of Thymosin Beta-4 (the actin-binding domain, amino acids 17–23). It retains the key biological activity of the full Thymosin Beta-4 molecule but is shorter and easier to synthesize. Some research uses the full Thymosin Beta-4 molecule, but TB-500 is more commonly available for research.

Dosage Reference

TB-500 Dosage Guide

Q: What is the standard TB-500 dosage?

The most commonly reported research protocol uses a loading phase of 4–8 mg/week (split into 2 injections) for 4–6 weeks, followed by a maintenance phase of 2–4 mg every 2 weeks. Acute injury protocols often use higher loading doses (8–10 mg/week) for the first 2 weeks to accelerate tissue repair.

Q: How long does TB-500 take to work?

Acute injuries typically show improvement within 2–4 weeks of the loading protocol. Chronic tendinopathies may take 6–12 weeks to show significant improvement. Cardiac repair effects (in animal models) are measurable within 4 weeks. Most researchers report noticeable recovery acceleration within the first 2 weeks.

Complete TB-500 dosage guide covering loading protocols, maintenance dosing, reconstitution, and cycling.

Source TB-500 at Purgo Labs Use code HEALTH for 15% off

TB-500 is a synthetic version of Thymosin Beta-4, an endogenous peptide involved in actin regulation, cell migration, and tissue repair. It is commonly used alongside BPC-157 for connective tissue and muscle recovery protocols.

Research Disclaimer: This dosage information is for educational and research purposes only. TB-500 is not FDA-approved for human use (unless otherwise noted). Always consult a qualified healthcare professional before considering any peptide protocol.

TB-500 Dosage Reference

Protocol	Dose	Notes
Loading Phase	4–8mg/week	Weeks 1–4. Higher dose to saturate tissue and initiate repair cascade.
Maintenance Phase	2–4mg/week	Weeks 5+. Reduced dose to maintain repair activity.
Acute Injury	5–10mg/week	Short-term high dose for acute injuries. Run for 2–4 weeks maximum.

Reconstitution

Reconstitute with bacteriostatic water. For a 5mg vial: add 1mL BAC water for a concentration of 5mcg/μL (500mcg per 0.1mL/10 units on a 100-unit insulin syringe).

Timing

Split weekly dose into 2 injections (e.g., Monday and Thursday) for more consistent blood levels. Timing relative to meals is not critical.

Cycle Length

Loading phase of 4–6 weeks followed by maintenance or a break. Many researchers cycle 4–6 weeks on, 4 weeks off.

Storage

Lyophilized powder: refrigerate at 2–8°C. Reconstituted: refrigerate, use within 30 days.

Calculate Your Exact Draw Volume

Use our free peptide calculator to convert your TB-500 dose into exact syringe units based on your vial concentration.

Open Peptide Calculator

Frequently Asked Questions

What is the standard TB-500 dosage?

A loading phase of 4–8mg/week for 4–6 weeks, followed by a maintenance dose of 2–4mg/week. Split into two injections per week for best results.

Should I use TB-500 with BPC-157?

Yes — this is the most common research stack. BPC-157 drives structural repair while TB-500 accelerates the inflammatory resolution phase. They work through complementary mechanisms.

How long does TB-500 take to work?

Most researchers report reduced pain and improved mobility within 2–4 weeks of the loading phase. Full structural repair takes 8–16 weeks.

BPC-157 vs TB-500 Comparison Best Peptides for Joint Pain All Dosage Guides

Related Guides

Comparison

BPC-157 vs Thymosin Alpha-1

By Condition

Best Peptides for Wound Healing

By Condition

Best Peptides for Joint Pain

Source Quality TB-500 for Research

Purgo Labs provides pharmaceutical-grade research peptides with third-party COAs. Use code HEALTH for 15% off your first order.

Visit Purgo Labs

Medical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.

The Definitive Peptide Research Reference Guide — Compound Review